Home Contact Sitemap

PedAM

Pediatric Disease Annotations & Medicines




Disease allergic asthma
Phenotype C0011849|diabetes mellitus
Sentences 2
PubMedID- 25291953 Omalizumab (anti-ige) therapy increases blood glucose levels in severe persistent allergic asthma patients with diabetes mellitus: 18 month follow-up.
PubMedID- 26075226 We showed that omalizumab therapy increases blood glucose levels in allergic asthma patients with diabetes mellitus.

Page: 1